Category Archives: Drug Safety

Rapid Update 3-November 2020: Drug Safety: Study suggests room for improvement with the pregnancy safety advice given to women prescribed RAS drugs

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 2 – August 2020: Methotrexate: study finds wide variation in “unsafe” prescribing across general practices and CCGs in England

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 1 – March 2020: Antibiotic prescribing: observational study finds macrolide antibiotic use in pregnancy is associated with an increased risk of birth defects.

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 2 – October 2019: Public health assessment finds a quarter of adults in England prescribed medicines associated with dependence or withdrawal

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.

Rapid Update 1 – February 2019 Hormone replacement therapy (HRT): Further evidence that oral but not transdermal HRT is associated with venous thromboembolism

This content is available to authorised users working in organisations that subscribe to ScriptSwitch only. Authorised users need to be logged in to read this content.

Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.